Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems
Kristen M Mackowick1, Mera S Barr2, Victoria C Wing2
1The Institute of Medical Sciences (IMS), University of Toronto, Toronto, Ontario Canada; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), University of Toronto, Toronto, Ontario Canada.
Summary
Individuals with schizophrenia smoke more and may use nicotine to improve cognitive deficits. Nicotine
Area of Science:
- Neuroscience
- Psychiatry
- Addiction Medicine
Background:
- Schizophrenia is linked to higher smoking rates and significant neurocognitive deficits.
- These deficits impact daily functioning and may predispose individuals to tobacco dependence.
- A dysregulated nicotinic acetylcholine receptor (nAChR) system may underlie this comorbidity.
Purpose of the Study:
- To explore the role of nicotine in potentially remediating neurocognitive deficits in schizophrenia.
- To investigate the shared vulnerability between schizophrenia and tobacco dependence.
- To understand the neurobiological mechanisms linking schizophrenia, cognitive function, and smoking.
Main Methods:
- Review of pre-clinical evidence on nicotine's effects on neurotransmitter systems.
- Analysis of studies examining nicotine administration in patients with schizophrenia.
- Assessment of neurocognitive outcomes, including reaction time, working memory, attention, and sensory gating.
Main Results:
- Nicotine administration can improve specific neuropsychological deficits in schizophrenia patients.
- These cognitive improvements are potentially more pronounced in individuals who smoke.
- Nicotine influences key neurotransmitter systems like dopamine, glutamate, and GABA.
Conclusions:
- Nicotine may offer symptomatic relief for cognitive impairments in schizophrenia.
- The nAChR system's role is crucial in understanding the high comorbidity of schizophrenia and smoking.
- Targeting nAChRs could be a potential therapeutic strategy for this population.
Related Concept Videos
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:15Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...